RNA Analysis/Transcriptomics Market Analysis and Forecast by 2031

MARKET OVERVIEW

RNA Analysis/Transcriptomics is the study of RNA transcripts outturned by genome of any organism, under specific circumstances or in a specific cell using high throughput methods. Comparison of transcriptomes enables in identifying genes that are differentially expressed in distinct cell populations, or in response to different treatments.

MARKET SCOPE

The "Global RNA Analysis/Transcriptomics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the RNA analysis/transcriptomics market with detailed market segmentation by product, technology, application, end user and geography. The report provides key statistics on the market status of the leading RNA analysis/transcriptomics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on product, the global RNA Analysis/Transcriptomics market is segmented into consumables, instruments, software and services.
  
•   The technology segment is classified into microarray, real-time quantitative polymerase chain reaction, and sequencing technologies.
  
•   Based on application the market is segmented into diagnostics and disease profiling, drug discovery and others.
  
•   Based on end user the market is segmented into government institutes and academic centers, pharmaceutical and biotechnological companies and contract research organization.
  

MARKET DYNAMICS

Drivers:

•   Increasing advancements in the field of transcriptomics such as advancements in RNA-sequencing technology
  
•   Growth in transcriptomics application
  
•   Increasing funding by various private and government organization
  
•   Increasing number of pharmaceutical and biotechnology companies
  
•   Continuous improvements in the healthcare infrastructure.
  

Restraints:

•   Dearth of skilled professionals
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The RNA analysis/transcriptomics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the RNA analysis/transcriptomics market in these regions.

IMPACT OF COVID-19 ON RNA ANALYSIS/TRANSCRIPTOMICS MARKET
All countries across the globe have been highly affected due to the outbreak of the COVID-19 pandemic. Countries such as the US and Canada reported the highest numbers of COVID-19 positive cases. The US-registered highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased demand for COVID diagnostics and therapeutics have dramatically increased in the hospitals.
The COVID-19 pandemic has negatively impacted all phases of drug development and forced many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold.
Further in North America, the COVID-19 pandemic has disrupted scientific research activities significantly. Research Laboratories have been forced to shut down. Researchers have been advised to work from home. Animal facilities have been scaled down and shipping of research supplies has been delayed.

MARKET PLAYERS

The report covers key developments in the RNA analysis/transcriptomics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from RNA analysis/transcriptomics market are anticipated to lucrative growth opportunities in the future with the rising demand for RNA analysis/transcriptomics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the RNA analysis/transcriptomics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Bio-Rad Laboratories Inc.
  
•   Illumina Inc.
  
•   GE Healthcare
  
•   F. Hoffmann-La Roche Ltd.
  
•   Agilent Technologies Inc.
  
•   Thermofisher Scientific Inc.
  
•   Sigma Aldrich
  
•   Qiagen N.V.
  
•   Affymetrix Inc.
  
•   Fluidigm Corporation
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

RNA Analysis/Transcriptomics Report Scope